07-24-2018 – ETBI – EastGate Biotech Provides Update on Investment From Genluiching Mining Corporation
EastGate to Receive the First Non-dilutive Investment Tranch from the Total Funding up to $5 million USD as per the Terms of the Definitive Agreement WEST CALDWELL, NJ and TORONTO, ON / ACCESSWIRE / July 24, 2018 / EastGate Biotech Corp. (OTC PINK: ETBI), a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of type 2 diabetes, announced that it is to receive the first tranch of the investment from Genluiching Mining Corporation as per the definitive agreement signed in April. As per the previously announced executed Definitive Agreement, Genluiching Mining will invest...
